title: [Treatment of children born of AIDS mothers in Tsevie hospital regional center, Togo].
abstract: The aim of this survey was to describe the components of the children medical care follow-up in the protocol of prevention of HIV/Aids from mother to child by nevirapine intake. A four-year retrospective study was carried out in Tsevie hospital regional center 90 children and their pregnant mothers who received nevirapine were recorded. 75 children received breast feeding. There was no follow-up for 42% of the children. The weight growth was correct in 90% of the children effectively followed. 49% of the children were completely vaccinated to PEV. The average children medical check up was 3.1 (minimum 1 maximum 8). The average age for breast feeding weaning was 6.2 months. The mother to child transmission rate was globally estimated at 12.5% at 18 months. 12 children (13%) died before HIV serology. The survey confirms the potency of nevirapine in preventing HIV transmission from mother to child and lays emphasis on real problems for which appropriate solutions should be found.
authors.affiliation: Service de pédiatrie, CHR de Tsévié, BP 51, Togo. edjadou@yahoo.fr
authors.forename: K E
authors.initials: KE
authors.lastname: Djadou
authors.forename: A
authors.initials: A
authors.lastname: Ocloo
authors.forename: D
authors.initials: D
authors.lastname: Dokounor
authors.forename: O
authors.initials: O
authors.lastname: Agbodjan-Djossou
authors.forename: A
authors.initials: A
authors.lastname: Akakpossa
authors.forename: D Y
authors.initials: DY
authors.lastname: Atakouma
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis; D019380:Anti-HIV Agents / Q000627:therapeutic use; D001942:Breast Feeding; D002662:Child Health Services; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006679:HIV Seropositivity / Q000175:diagnosis; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D008297:Male; D019829:Nevirapine / Q000627:therapeutic use; D011247:Pregnancy; D012189:Retrospective Studies; D014037:Togo; D014611:Vaccination; D015430:Weight Gain / Q000187:drug effects
chemical_list: D019380:Anti-HIV Agents; D019829:Nevirapine